Sponsored By

CBD opportunity: Smart brands capitalize on market expansionCBD opportunity: Smart brands capitalize on market expansion

Despite regulatory ambiguity, the hemp-derived cannabidiol (CBD) market generated $390 million for 2018 in the United States. Conservative estimates place the market at more than a billion dollars by 2020. The late December passage of the 2018 Farm Bill legalized hemp and hemp derivatives, including CBD. Although FDA has maintained its position against the use of CBD in food and dietary supplements, the agency hinted a pathway forward may exist.

January 31, 2019

1 Min Read

Takeaways for your business

• Investors are taking an increasing interest in the market for hemp-derived CBD. 
• Hemp-derived CBD at or below 0.3% THC is no longer considered a controlled substance.
• Globally, CBD and THC appear in supplements, topical analgesics, beverages and skin care products.

Underwritten by:



Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like